ArticleFolia microbiologica2026
Ignatzschineria indica bacteremia in a fatal case of accidental wound myiasis.
Article in Folia microbiologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Ignatzschineria indica is a rare Gram-negative bacterium increasingly recognized as a potential human pathogen associated with wound myiasis and severe bloodstream infections. Here we report a fatal case of I. indica bacteremia in a 63-year-old woman admitted to the intensive care unit with septic shock. The patient had arterial hypertension and liver cirrhosis and was found after prolonged immobilization in severely neglected conditions. Clinical examination revealed extensive pressure ulcers complicated by maggot infestation and a left pertrochanteric femoral fracture. Blood cultures became positive for Gram-negative rods, with the isolate identified by mass spectrometry as I. indica. Antimicrobial susceptibility tests using gradient diffusion demonstrated susceptibility to all tested antibiotics (cefotaxime, cefepime, meropenem, piperacillin/tazobactam, ciprofloxacin, trimethoprim-sulfamethoxazole and gentamicin). However, despite intensive care management, broad-spectrum antimicrobial therapy, and surgical wound debridement, the patient developed progressive multiorgan failure and died from refractory septic shock. Subsequently, the presence of I. indica in the blood culture was confirmed by whole-genome sequencing, showing a 98.8% average nucleotide identity with the reference genome. This case highlights the pathogenic potential of I. indica in patients with neglected myiasis-associated wounds. The rarity lies particularly in the fact that despite all modern available care (including necrectomy, debridement, and treatment with suitable antibiotics), the patient died within three days of admission. This is unique in Central Europe, where no report on lethal infection with I. indica has been reported so far. Hence, this paper can serve as a valuable piece of knowledge on the treatment of maggot-infested wounds, particularly where I. indica infections are concerned.
Indexed as
Identifiers
42782458What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.